Products

Prima RNApols™

Wondering which RNApol is right for you?

The table below provides a comprehensive comparison of performance characteristics across our current and upcoming product portfolio, enabling informed selection based on your specific process requirements and quality attributes.
Product YIELD^ Reduced dsRNA^^ CAPPING Nucleotides
(Modified & Unmodified)
T7 Promoter
Compatibility
Linear <5 kb Linear >5 kb & saRNA AG Cap Analog AU Cap Analog Enzymatic
Capping
Prima ExTend
Available Now
✓✓✓ ✓✓✓ No
Prima ExTend Cap AU
Available Now
✓✓✓ ✓✓✓ ✓✓✓ No
Prima Cap AG
2H 2026 Release
✓✓✓ ✓✓✓ ✓✓✓ No
Prima Drop-in
2H 2026 Release
✓✓ ✓✓ ✓✓ ✓✓ ✓✓ Yes

✓✓✓ Substantive Improvement over T7

✓✓ Improvement over T7

Greater than or equal to performance with T7

^ Yield of target mRNA per unit of IVT input (DNA template, Cap Analog, etc)

^^ & Other IVT by-products, abortive transcripts, etc

Source Our Prima RNApols

By outperforming the industry-standard T7 RNA polymerase, our Prima RNApols improve the cost and quality profiles of pharmaceutical mRNA manufacturing across formats (linear, self-amplifying, circular) and a range of DNA template sequences and lengths, while remaining compatible with various capping chemistries, modified nucleotides, and IVT conditions.

Prima ExTend Cap AU

Contains 20,000 U RNA Polymerase
(100 µL)

For Research Use Only

Prima ExTend Kit

Contains the following for 50 IVT reactions:
20,000 U RNA Polymerase (100 µL)
4, 5x Reaction Buffer (100 µL)
2 kb Linearized DNA Template (25 µL)

For Research Use Only

Prima ExTend GMP

Contains 20,000 U RNA Polymerase
(100 µL)

GMP-grade Prima RNApols are manufactured and released under ISO 13485:2016 certified quality systems.

Prima ExTend GMP – Large

Contains 2,000,000 U RNA Polymerase
(10 mL)

GMP-grade Prima RNApols are manufactured and released under ISO 13485:2016 certified quality systems.